CME Group Inc. (CME)
CME Group (CME) Earnings Expected to Grow: Should You Buy?
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
As Chicago Thaws In Spring, CME Group Remains A Hot Dividend Idea
CME Group gets a strong buy rating yet again, driven both by fundamental and technical factors, despite a neutral consensus. Company growth factors, macro-level tailwinds, strong margins, and low leverage combine to form a convincing mix. The dividend growth is proven over 10 years and many market cycles, while the payout ratio appears sustainable.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
CME Group Outperforms Industry, Trades at a Premium: Hold Now?
CME shows steady growth, strong dividends, and resilience, but with limited upside at current valuations, investors may consider holding the stock for now.
Azimuth Capital Investment Management LLC Sells 2,764 Shares of CME Group Inc. $CME
Azimuth Capital Investment Management LLC trimmed its stake in CME Group Inc. (NASDAQ: CME) by 8.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,189 shares of the financial services provider's stock after selling 2,764 shares during the period. Azimuth
CME Group Inc. $CME Stake Reduced by Arrowstreet Capital Limited Partnership
Arrowstreet Capital Limited Partnership cut its stake in CME Group Inc. (NASDAQ: CME) by 25.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,866,455 shares of the financial services provider's stock after selling 966,635 shares during the period. Arrowstreet
CME (CME) Up 6.5% Since Last Earnings Report: Can It Continue?
CME (CME) reported earnings 30 days ago. What's next for the stock?
CME Group Inc. (CME) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
CME Group Inc. (CME) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript
CME outage derails silver rally at critical moment, sparking confusion, suspicion and outrage
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
